This discovery is noteworthy as it indicates that Mcl-1 inhibition could be a more effective approach for MM treatment, especially in instances when conventional chemotherapies or immunomodulatory agents do not yield lasting results. Here, MCL1 is linked to Miyoshi myopathy.